Singapore Pandemic Preparedness And Response Framework

Pandemic Preparedness and Response National Health Strategy 2025
Singapore English PDF
National

AI-Generated Document Summary

Objectives

Singapore’s 2025 Pandemic Preparedness and Response Framework provides a disease-agnostic, modular and adaptable basis for preparing for and responding to infectious disease outbreaks caused by known or novel pathogens.Its overarching outcomes are to save lives and protect livelihoods by balancing health protection with social and economic stability.

  • Build integrated, scalable and agile systems during peacetime that can be tailored to pathogen characteristics, transmission dynamics, prevailing risk and outbreak context.
  • Prevent infections, identify cases early, provide prompt and effective treatment, and protect vulnerable and at-risk populations.
  • Maintain international connectivity, trade, essential travel and essential societal functions while reducing importation risks and minimising disruption.
  • Organise preparedness and response across detection, surveillance and sense-making; point-of-entry measures; healthcare provision; medical countermeasures; and population-based measures.
  • Integrate human, animal, vector and environmental considerations through a One Health approach to address zoonotic, food, water, wastewater and environmental risks.
  • Apply proportionate, evidence-based, feasible and sustainable measures, refining interventions as epidemiological evidence, scientific knowledge and implementation experience evolve.

The framework also seeks to unify government capabilities and response mechanisms, optimise resource allocation, incorporate lessons from past events, and enable organisations to develop plans appropriate to their own functions and challenges.It is aligned with the approach proposed by the World Health Organization and is intended to be updated as science, technology and new response measures develop.

Implementation

Implementation relies on whole-of-government coordination, multisectoral One Health collaboration, community participation, private-sector partnerships, international engagement and enabling functions including legislation, communications, research and development, knowledge management, fiscal policy, technology, resources and environmental and social planning.The Communicable Diseases Agency, a statutory board under the Ministry of Health, leads national efforts to prevent, detect, prepare for, manage and control infectious diseases.

  • Coordinate national incident management through the Homefront Crisis Management System, with the Homefront Crisis Executive Group bringing together ministries and the Ministry of Health chairing the Crisis Management Group for Health.
  • Provide strategic One Health direction through the One Health Coordinating Committee, while the One Health Working Group formulates, coordinates, implements and reviews aligned programmes.
  • Apply the Infectious Diseases Act 1976 as the principal legal basis for notification, isolation, contact tracing, quarantine, public health declarations and other outbreak measures.
  • Conduct horizon scanning, validate and assess threat signals, combine passive and active surveillance, and share relevant international health information under the International Health Regulations.
  • Operate integrated human infectious disease surveillance using indicator-based, syndromic, sentinel, event-based and community-testing approaches, supported by reporting from clinicians, laboratories, healthcare providers, institutions and the public.
  • Undertake epidemiological investigations, joint One Health risk assessments, mathematical modelling and forward planning to identify transmission chains, assess risks, forecast scenarios and plan resources.
  • Deploy risk-calibrated point-of-entry measures, including travel advisories, health declarations, screening, testing, segregation, quarantine and conveyance or goods decontamination, while preserving essential travel and cargo movement where possible.
  • Maintain healthcare resilience through accessible primary care, centralised management of novel infections at the National Centre for Infectious Diseases where appropriate, surge activation of public hospitals, flexible facilities and workforce expansion.
  • Develop, authorise, stockpile, supply and deploy medical countermeasures, including personal protective equipment, diagnostics, vaccines and therapeutics, using flexible risk-based regulatory pathways where necessary.
  • Implement population-based measures such as respiratory and environmental hygiene, ventilation, physical distancing, remote working, isolation, contact tracing, quarantine, vaccination-differentiated measures and targeted service restrictions according to risk.

Delivery involves government agencies within and beyond health, healthcare institutions and providers, research and academic communities, private healthcare providers, manufacturers, logistics businesses, grassroots organisations, non-governmental organisations, community groups and volunteers.International collaboration with other countries, the Association of Southeast Asian Nations and the World Health Organization supports information exchange, risk assessment, genomic surveillance and policy coordination.

Operational learning is supported by outbreak documentation, after-action reviews, tabletop exercises, simulation drills, workforce training and systematic knowledge management across institutions.Public communication is intended to be timely, transparent, evidence-based and actionable, while addressing misinformation, responding to community concerns and supporting adherence to necessary measures.

The framework does not specify a consolidated set of quantitative performance indicators, reporting schedules, independent accountability arrangements, budget allocations, funding gaps or total financing requirements.It identifies fiscal support, healthcare infrastructure, surge resources, medical supplies, research, social support and public health education as resourcing priorities.

Monitoring & Evaluation

The framework establishes a broad, adaptive monitoring and learning system centred on horizon scanning, integrated surveillance, epidemiological investigation, risk assessment, modelling, operational review and cross-sector coordination. It supports early threat detection, tailored response measures and continuous adaptation, but does not set out a consolidated quantitative indicator framework, standard reporting schedule or independent accountability architecture.

  • Conduct horizon scanning across official, informal and restricted sources, validate and triage signals, and use appropriate information-processing tools, including artificial intelligence, to identify threats relevant to Singapore.
  • Operate integrated human infectious disease surveillance through passive, active, indicator-based, syndromic, sentinel, event-based and community-testing approaches, drawing on reports from clinicians, laboratories, healthcare providers, institutions and the public.
  • Require notification of legally prescribed diseases to the Director-General of Health and prescribe newly identified diseases of concern where necessary to support timely reporting and control action.
  • Use structured case, laboratory, primary-care, hospital-attendance and admission data to track trends, detect outbreaks and inform public health measures.
  • Monitor syndromic signals, unusual health-event reports, unexplained deaths and critical illness to support early detection of novel pathogens.
  • Collect representative sentinel-site data, including respiratory surveillance, to identify circulating pathogens, guide interventions and monitor the effectiveness of control measures.
  • Use community testing data to assess prevalence, geographical distribution and risk factors, selecting testing methods according to diagnostic performance, disease characteristics, target population, resources and turnaround time.
  • Undertake laboratory reporting, pathogen characterisation, variant tracking, diagnostic-method validation, seroprevalence surveys and zoonotic surveillance to assess transmission, immunity and immunisation programme effectiveness.
  • Integrate human, animal, food, water, wastewater, vector and environmental surveillance through a One Health approach, with coordinated roles for the Communicable Diseases Agency, National Environment Agency, National Parks Board, Singapore Food Agency and Singapore’s National Water Agency.
  • Use food, water, wastewater and vector surveillance to identify hazards, monitor disease trends and trigger targeted case finding or interventions; wastewater monitoring expanded to more than 500 autosamplers nationwide during COVID-19 and tested up to 5,000 samples weekly at its peak.
  • Conduct epidemiological investigations using case definitions, interviews, contact tracing, surveys, environmental sampling, testing, statistical analysis and, where appropriate, genomic sequencing to identify infection sources, transmission chains and risk factors.
  • Undertake rapid and repeated quantitative and joint One Health risk assessments, using suitable indicators such as disease incidence and vaccine coverage, to reflect changing epidemiology and the effects of implemented measures.
  • Apply mathematical and statistical modelling, sensitivity analysis and counterfactual scenarios to forecast outbreaks, estimate healthcare, quarantine and contact-tracing needs, compare interventions and assess wider disruption.
  • Monitor points-of-entry measures through traveller screening, health declarations, testing performance, quarantine testing and updated electronic health-declaration questions that identify potentially high-risk travellers.
  • Require quarantined people to monitor their health, record temperature twice daily and report through a mobile application, supported by random compliance checks through telephone, video and in-person contact.
  • Maintain surveillance of national infection prevention and control indicators and antimicrobial stewardship programmes, reviewing personal protective equipment, cleaning, disinfection and environmental-control requirements as transmission evidence changes.
  • Monitor the effectiveness, safety, stockpile composition and deployment gaps of medical countermeasures, updating clinical recommendations and supply arrangements as local and global evidence develops.
  • Review business continuity plans through testing and exercises, maintain regular testing and symptom monitoring for frontline workers, and enforce vector-breeding controls where required.
  • Use situational updates and public health assessments through the Health Crisis Management Group, while the One Health Working Group reviews aligned programmes and adapts measures in response to evidence, risk assessments and community feedback.
  • Document outbreaks, conduct after-action reviews, tabletop exercises and simulation drills, assess workforce competencies and convert identified gaps into structured improvement actions.

Costing & Financing

The framework recognises financing, fiscal policy, resources and operational feasibility as essential enablers of pandemic preparedness and response, but it does not provide quantified budgets, allocations, funding gaps, financing targets or economic assumptions.

  • Assess the feasibility of measures against available manpower, equipment, infrastructure and public health budget, alongside public understanding and acceptance.
  • Avoid approaches requiring excessive additional resources or support, while accounting for their longer-term psychological, social and economic effects.
  • Use pre-entry controls where suitable because they are generally less resource-intensive than post-entry measures, particularly during large-scale outbreaks.
  • Balance points-of-entry interventions against economic implications and adjust them as local community transmission changes.
  • Manage resources through redeployment of personnel, repurposing of healthcare infrastructure and prioritisation of staff, medical supplies and equipment during surges.
  • Consider cost-effectiveness and operational feasibility when maintaining essential medical-countermeasure supplies, stockpiles and supply-chain resilience.
  • Provide financing for healthcare infrastructure and surge capacity, vaccines and therapeutics, research and development, social-support programmes and public health education campaigns.
  • Use fiscal policies to support public health and social measures, expand medical countermeasures and healthcare services, and assist individuals and sectors economically affected by outbreaks.
  • Draw on the COVID-19 Unity, Resilience, Solidarity and Fortitude budgets, which included cash payouts, wage subsidies, tax rebates and increased healthcare spending for households, businesses and vulnerable sectors.
  • Recognise that movement restrictions, physical distancing and service cessation can disrupt businesses and livelihoods, contribute to social isolation and mental-health challenges, and create wider economic and social impacts.
  • Mobilise private-sector expertise, infrastructure, manufacturing, logistics, data analytics and healthcare-delivery capacity as contributions to preparedness and response, without specifying financing mechanisms or allocations.

Document Viewer